Roy Calne
![A bronze bust of Calne by sculptor [[Laurence Broderick]], outside the main operating theatres at [[Addenbrooke's Hospital]]](https://upload.wikimedia.org/wikipedia/commons/7/77/Sir_Roy_Caine_bronze_bust_by_Laurence_Broderick.jpg)
In 1960, Calne showed that 6-mercaptopurine (6-MP) could prolong the survival of a transplanted kidney in a dog, and later showed that azathioprine was more effective. Through the mid-1960s, he worked to develop solutions in surgical techniques and organ rejection. In the late 1970s, he began to experiment with the immunosuppressant ciclosporin A, which was then introduced into regular use to prevent organ rejection.
Calne was elected to the Royal Society in 1974, and was awarded the 1988 Cameron Prize for Therapeutics of the University of Edinburgh. He was awarded the 1984 Lister Medal, and knighted two years later. In 1990, he received the Ellison-Cliffe Medal from the Royal Society of Medicine. In 2012, he shared a Lasker-DeBakey Clinical Medical Research Award with Thomas Starzl. Provided by Wikipedia
1